MDT Search Earning

Medtronic plc

MDT

Medtronic Plc. gained 0.3% to $86.30 after the American-Irish medical device company reported results for the fiscal 2025 third quarter.

Revenue increased 2.5% to $8.29 billion from $8.09 billion, net income dropped to $1.29 billion from $1.32 billion, and diluted earnings per share rose to $1.01 from 99 cents a year ago.

Sales in the cardiovascular, medical surgical, and diabetes segments marked a steady growth in the quarter, while the neuroscience segment dropped 3.7% to $769 million from $799 million in the same period last year.

For the full year, Medtronic estimated non-GAAP earnings growth between 4.6% and 5.8% in the range of $5.44 to $5.50 per share.
Feb 19, 2025

Year	Jul	Oct	Jan	Apr	Annual

2023	0.92	0.88	0.59	0.68	-
2022	1.1	1.1	0.7	0.32	2.82
2021	0.94	1	0.56	0.97	3.73
2020	1.42	0.47	0.36	0.36	2.66
2019	0.94	0.86	0.64	1.01	3.54
2018	-1.03	1.08	0.79	0.82	3.41
2017	1.12	1.33	1.12	1.07	4.64
2016	1.06	1.27	1.03	1.12	4.48
2015	1.01	1.16	1.02	1.03	4.22
2014	0.87	0.83	0.75	0.45	3.02
2013	0.93	0.89	0.97	0.94	3.37
2012	0.83	0.63	0.88	0.94	3.41
2011	0.77	0.82	0.86	0.72	2.86
2010	0.76	0.52	0.75	0.86	2.79
2009	0.40	0.78	0.62	0.10	1.84
2008	0.64	0.48	0.07	0.63	1.87
2007	0.59	0.58	0.61	0.70	2.41
2006	0.51	0.59	0.55	0.61	2.09
2005	0.26	0.67	0.45	0.16	1.48